Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05549362 · ClinicalTrials.gov registry record · NA
DiAL Health Research Study
A NA study of Aging and Weight Loss, sponsored by Pennington Biomedical Research Center.
- Active
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT05549362: Active NA study of Aging and Weight Loss, sponsored by Pennington Biomedical Research Center.
NCT05549362 is a NA study of Aging and Weight Loss that is active but no longer recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 90 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05549362, a NA study of Aging and Weight Loss, is active but no longer recruiting, sponsored by Pennington Biomedical Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to conduct a five-arm pilot and feasibility trial in healthy, young individuals without obesity to evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.
Primary Outcome
Intervention satisfaction will be assessed via Likert ratings for each study group.
Conditions Studied
Interventions
- OTHER Dial Health Research Study
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT05549362 still lists
NCT05549362 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Dial Health Research Study is the first listed.
NCT05549362 reports a single indexed study location in Alabama, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05549362 about?
NCT05549362 is a clinical study titled "DiAL Health Research Study". The purpose of this study is to conduct a five-arm pilot and feasibility trial in healthy, young individuals without obesity to evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.
What is the current status of trial NCT05549362?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-12-02. Estimated completion is 2025-12-31.
What conditions does trial NCT05549362 study?
This clinical trial studies the following conditions: Aging, Weight Loss, Treatment Adherence.
What interventions are being tested in trial NCT05549362?
The interventions under investigation include: Dial Health Research Study (OTHER).
Who is sponsoring clinical trial NCT05549362?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05549362 being conducted?
This trial has 2 study locations across Alabama, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05549362's enrollment target sits among peer trials
90 99th of 262 higher than 159 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI